More I digest 4c more things I like:
Unaudited consolidated revenue for 1H FY22 of $7.1 million, up 35% on the prior
corresponding period, with invoicing of customers for both key business segments
(full-curriculum and VET-in-Schools) still occurring;
So really when talking about growth rates, we need to remember last Q was strong YoY and there may still be cash receipts still to hit the books from this one. Rev rate for half year healthy at 35% YoY. My overarching question for this result was can the company show its back to growth. Looks like answer is yes.
Company looks to be getting back into gear after some setbacks from reseller and covid.
IMO, DYOR
MJ
- Forums
- ASX - By Stock
- Ann: March 2022 Quarterly Report and Appendix 4C
RCL
readcloud limited
Add to My Watchlist
4.55%
!
10.5¢

More I digest 4c more things I like:Unaudited consolidated...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $16.13M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $440 | 4.179K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 80523 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 45454 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 80523 | 0.105 |
5 | 179125 | 0.100 |
1 | 38000 | 0.099 |
2 | 325000 | 0.097 |
2 | 110250 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 45454 | 1 |
0.115 | 33272 | 1 |
0.120 | 2618 | 1 |
0.130 | 50000 | 1 |
0.135 | 58909 | 1 |
Last trade - 14.21pm 01/08/2025 (20 minute delay) ? |
Featured News
RCL (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online